Clinical Trial Update: Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

View source ↗

Summary

A clinical trial update describing a study that uses patient-derived organoids and circulating tumor cells to evaluate treatment response in lung cancer, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Lung Neoplasm | Status: RECRUITING